News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SEGAL SCOTT
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/08/2016 |
4
| SEGAL SCOTT (Director) has filed a Form 4 on Protea Biosciences Group, Inc.|
Txns:
| Acquired 418,552 shares
@ $0
Acquired 10,464 shares
@ $0
Granted 80,000 shares
@ $0
Granted 66,667 options to buy
@ $0.25, valued at
$16.7k
|
|
| 11/05/2014 |
4
| SEGAL SCOTT (Director) has filed a Form 4 on Protea Biosciences Group, Inc.|
Txns:
| Converted 52,319 convertible preferred
@ $0
Converted 209,276 warrants
@ $0.375, valued at
$78.5k
Converted convertible notes
@ $0 |
|
| 05/19/2014 |
4
| SEGAL SCOTT (Director) has filed a Form 4 on Protea Biosciences Group, Inc.|
Txns:
| Bought 31,250 options
@ $0.55, valued at
$17.2k
Bought 181,818 convertible notes
@ $0.55, valued at
$100k
Bought 109,091 warrants
@ $0.8, valued at
$87.3k
|
|
| 02/13/2014 |
4
| SEGAL SCOTT (Director) has filed a Form 4 on Protea Biosciences Group, Inc.|
Txns:
| Bought 50,000 shares
@ $2, valued at
$100k
Bought 388,038 shares
@ $0.5, valued at
$194k
Bought 25,000 warrants
@ $2.25, valued at
$56.3k
Bought 291,029 warrants
@ $1.1, valued at
$320.1k
Converted 388,038 convertible notes
@ $0.5, valued at
$194k
Granted 100,000 options
@ $1.5, valued at
$150k
Granted 218,750 options
@ $0.55, valued at
$120.3k
|
|
| 09/12/2011 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 09/12/2011 |
3
| SEGAL SCOTT (Director) has filed a Form 3 on Protea Biosciences Group, Inc. |
|
|